Cargando…
The Value of Cancer Immunotherapy Summit at the 2016 Society for Immunotherapy of Cancer 31(st) anniversary annual meeting
As healthcare costs continue to rise, there has been great interest in understanding and defining the value of current therapeutic strategies for the treatment of cancer. Cancer immunotherapy has emerged as a clinically beneficial alternative to conventional therapies for a variety of malignancies....
Autores principales: | Kaufman, Howard L., Atkins, Michael B., Dicker, Adam P., Jim, Heather S., Garrison, Louis P., Herbst, Roy S., McGivney, William T., Silverstein, Steven, Wigginton, Jon M., Yu, Peter P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394621/ http://dx.doi.org/10.1186/s40425-017-0241-6 |
Ejemplares similares
-
Highlights of the 31st annual meeting of the Society for Immunotherapy of Cancer (SITC), 2016
por: Gulley, James L., et al.
Publicado: (2017) -
Fiftieth Anniversary at the summit
Publicado: (2005) -
New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31(st)Annual Meeting of the Society for Immunotherapy of Cancer, 2016
por: Adusumilli, Prasad S., et al.
Publicado: (2017) -
Defining current gaps in quality measures for cancer immunotherapy: consensus report from the Society for Immunotherapy of Cancer (SITC) 2019 Quality Summit
por: Pai, Sara, et al.
Publicado: (2020) -
CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy
por: Kranz, Lena M., et al.
Publicado: (2017)